66 results
8-K
EX-99.1
MREO
Mereo Biopharma Group Plc
14 Jun 24
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market
4:30pm
Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by telephone at (877) 821-7388, or by email at prospectus_department … @jefferies.com; Leerink Partners LLC, Attention: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, by telephone at (800) 808-7525, ext. 6105
8-K
EX-1.1
MREO
Mereo Biopharma Group Plc
14 Jun 24
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market
4:30pm
or enforced by the United States Government (including, without limitation, the U.S. Department of the Treasury’s Office of Foreign Assets Control … , or the U.S. Department of State), the United Nations Security Council, the European Union, His Majesty’s Treasury, or other relevant sanctions
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
of any sanctions administered or enforced by the United States Government (including, without limitation, the U.S. Department of the Treasury’s Office … of Foreign Assets Control, or the U.S. Department of State), the United Nations Security Council, the European Union, His Majesty’s Treasury, or other
10-K
2023 FY
EX-10.30
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
or political subdivision, department or agency of a government;
“Phase II” means a human clinical trial of a Product in any country that would satisfy … , exemption of, or filing or registration with any court or governmental department, commission, board, bureau, agency or instrumentality, domestic
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
agreement. See "—Material Agreements—Licensing Agreement for Leflutrozole".
Government Regulation
Among others, the FDA, U.S. Department of Health … permits the Secretary of the Department of Health and Human Services, or HHS, to implement many of these provisions through guidance, as opposed
10-K
EX-19.1
z7hixj51bf 1zw
27 Mar 24
Annual report
5:20pm
6-K
EX-99.2
ylsgsalz45l7c jtpr
7 Sep 23
Current report (foreign)
7:37am
6-K
11wvh
8 May 23
Current report (foreign)
4:07pm
6-K
EX-99.1
kbx81mg0p dt1a
8 May 23
Current report (foreign)
4:07pm
6-K
EX-99.1
b1itgyaag2ir9hel72m
5 May 23
Mereo BioPharma Announces Listing Transfer to Nasdaq Capital Market
5:06pm
6-K
hgu4rlr 8y3s6vb9
5 May 23
Mereo BioPharma Announces Listing Transfer to Nasdaq Capital Market
5:06pm
6-K
EX-99.2
9xvj7h
2 Nov 22
Current report (foreign)
4:17pm
6-K
32e cpv5uk3mjc26o62t
2 Nov 22
Mereo BioPharma Received Notification of Nasdaq Minimum Bid Price Deficiency
4:07pm
6-K
EX-99.1
80d5pz49v92pmiqv1
2 Nov 22
Mereo BioPharma Received Notification of Nasdaq Minimum Bid Price Deficiency
4:07pm
6-K
EX-99.2
7hexd4
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
6-K
EX-99.1
ihfr05
5 Jul 22
Current report (foreign)
4:15pm
6-K
yxo7smgw55r8plp8
25 May 22
Current report (foreign)
4:11pm